We respond to new research, presented at the Advanced Breast Cancer Sixth International Consensus Conference, titled “Major global study reveals risk of breast cancer spreading to other parts of the body

Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said: “Around 1,000 women in the UK die each month from...

3 November 2021

We respond to draft NICE decision to not recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS

The National Institute for Health and Care Excellence (NICE) has today (Tuesday 26 October 2021) announced its provisional decision to not recommend...

26 October 2021

We respond to Macmillan Cancer Support's warning of 'perfect storm' of Covid and staff shortages

Mia Rosenblatt, Associate Director of Policy, Evidence and Influencing at Breast Cancer Now, said: “Cancer nurses are vital for patients,...

22 October 2021

We respond to a new study into eating nuts and breast cancer recurrence

Dr Kotryna Temcinaite, Senior Research Communications Manager, at Breast Cancer Now, said: “It is encouraging that eating nuts could potentially...

20 October 2021

We respond to a report from the IPPR and CF suggesting it could take over a decade to clear the cancer treatment backlog in England

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “These alarming estimates lay bare just how urgently investment in...

24 September 2021

We respond to new data for Enhertu presented at the European Society for Medical Oncology (ESMO) conference

Dr Kotryna Temcinaite, Senior Research Communications Manager Breast Cancer Now, said: “It is fantastic to see that trastuzumab deruxtecan (...

19 September 2021

We respond to news of NHS England and Amgen reaching a national agreement to enable early access to Sotorasib for eligible lung cancer patients in England

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Lung cancer patients today received welcome news of interim access to a...

10 September 2021

We respond to Macmillan Cancer Support's new research revealing severe nurse shortages are putting cancer patients at risk

Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said: “These revelations paint a really frightening...

8 September 2021

Breast Cancer Now welcomes NICE approval of abemaciclib with fulvestrant for routine use on the NHS

The National Institute for Health and Care Excellence (NICE) has today (Thursday 12th August 2021) announced its decision to approve abemaciclib with...

12 August 2021